Cardiothoracic & vascular anesthesia

Multicenter Study to Evaluate Endovascular Repair of Extent I-III Thoracoabdominal Aneurysms Without Prophylactic Cerebrospinal Fluid Drainage

Ann SurgPublished Multicentre cohort study

Authors' conclusion

FB-EVAR of Extent I-III TAAAs without CSFD has low mortality and low rates of permanent paraplegia (2%). SCI occurred in 8% of patients, and rescue treatment improved symptoms in 73% of them.

Study context

Population
Patients treated for Extent I–III thoracoabdominal aortic aneurysms by fenestrated-branched endovascular aortic repair (FB-EVAR) without prophylactic cerebrospinal fluid drainage22 Extent I, 240 Extent II, 279 Extent III
Participants
541 patients
Exposure
Extent I-II vs Extent III
  • Extent IIIn = 279reference
Outcome
Any spinal cord injury (SCI)
Methodological detailsno prophylactic cerebrospinal fluid drainage
  • No prophylactic cerebrospinal fluid drainage

Main finding

As reported in the abstract

Spinal cord injury (SCI), all patients

45

8%

Paraparesis

23

4%

Paraplegia

22

4%

Permanent paraplegia

12

2%

Observational data: associations, not effects.

Further findings

SCI by TAAA extent

P = 0.01

Independent predictors of SCI (multivariate logistic regression)

OR (95% CI)
Sustained perioperative hypotension4.4 (1.7–11.1)
Patent collateral network0.3 (0.1–0.6)
Total length of aortic coverage1.05 (1.01–1.10)

Rescue treatment for SCI

Permissive hypertension in all patients; Cerebrospinal fluid drainage (CSFD)
22 (4%)
Symptom improvement
73%

Patient survival · 3 years

Survival
72%±3%

30-day mortality

Mortality
3%

Safety

Major drain-related complications
2 (0.4%)

Original publication

Multicenter Study to Evaluate Endovascular Repair of Extent I-III Thoracoabdominal Aneurysms Without Prophylactic Cerebrospinal Fluid Drainage. Ann Surg. Published 4 August 2022. doi:10.1097/sla.0000000000005653

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.